Cargando…

An overview of select cannabis use and supply indicators pre- and post-legalization in Canada

BACKGROUND: Canada implemented the legalization and regulation of non-medical cannabis use, production and sale in 2018 aiming to improve public health and safety. While outcomes from legalization reforms in other jurisdictions mostly rely on US-based data have been assessed to be mixed, Canadian da...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Benedikt, Lee, Angelica, Robinson, Tessa, Hall, Wayne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496143/
https://www.ncbi.nlm.nih.gov/pubmed/34620191
http://dx.doi.org/10.1186/s13011-021-00405-7
_version_ 1784579695310798848
author Fischer, Benedikt
Lee, Angelica
Robinson, Tessa
Hall, Wayne
author_facet Fischer, Benedikt
Lee, Angelica
Robinson, Tessa
Hall, Wayne
author_sort Fischer, Benedikt
collection PubMed
description BACKGROUND: Canada implemented the legalization and regulation of non-medical cannabis use, production and sale in 2018 aiming to improve public health and safety. While outcomes from legalization reforms in other jurisdictions mostly rely on US-based data have been assessed to be mixed, Canadian data are only emerging. We compiled select population-level data on key indicators to gauge initial developments from pre- to post-legalization of cannabis in Canada. METHODS: We examined indicators data focusing on the following topics: prevalence of cannabis use, frequency of use, methods/products of consumption, driving after cannabis use, and cannabis sourcing. Indicator data were obtained mostly from national and some provincial population surveys. Prevalence or percentages for the indicators pre- and post-legalization (e.g., 2017- 2020), including confidence intervals were reported, with changes noted, as available in and indicated by the data sources. RESULTS: Data suggested selected increases in cannabis use prevalence, mostly among mid- and older- but possibly also younger (e.g., under legal use age) users. Frequency of use and driving after cannabis use among active users do not appear to have changed. Methods of cannabis use show diversifying trends, with decreases in smoking and increases in alternatives use modes (e.g., edibles, vaping). There is a clearly increasing trend towards accessing cannabis from legal sources among adults, while under-legal-use-age youth do not appear to experience heightened barriers to obtaining cannabis in legalization contexts. CONCLUSIONS: Preliminary indicators on cannabis legalization in Canada show a mixed picture, some similar to US-based developments. While some use increases are observed, these do not necessarily represent indications of increases in cannabis-related harm, also since key (e.g., hospitalization or injury) data are lacking to date. There is a gradual embracing of legal supply sources of cannabis among users, which can be expected to serve public health and safety objectives. At the same time, cannabis use and access among under-age users as a principally vulnerable group do not appear to be hindered or reduced by legalization.
format Online
Article
Text
id pubmed-8496143
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84961432021-10-08 An overview of select cannabis use and supply indicators pre- and post-legalization in Canada Fischer, Benedikt Lee, Angelica Robinson, Tessa Hall, Wayne Subst Abuse Treat Prev Policy Short Report BACKGROUND: Canada implemented the legalization and regulation of non-medical cannabis use, production and sale in 2018 aiming to improve public health and safety. While outcomes from legalization reforms in other jurisdictions mostly rely on US-based data have been assessed to be mixed, Canadian data are only emerging. We compiled select population-level data on key indicators to gauge initial developments from pre- to post-legalization of cannabis in Canada. METHODS: We examined indicators data focusing on the following topics: prevalence of cannabis use, frequency of use, methods/products of consumption, driving after cannabis use, and cannabis sourcing. Indicator data were obtained mostly from national and some provincial population surveys. Prevalence or percentages for the indicators pre- and post-legalization (e.g., 2017- 2020), including confidence intervals were reported, with changes noted, as available in and indicated by the data sources. RESULTS: Data suggested selected increases in cannabis use prevalence, mostly among mid- and older- but possibly also younger (e.g., under legal use age) users. Frequency of use and driving after cannabis use among active users do not appear to have changed. Methods of cannabis use show diversifying trends, with decreases in smoking and increases in alternatives use modes (e.g., edibles, vaping). There is a clearly increasing trend towards accessing cannabis from legal sources among adults, while under-legal-use-age youth do not appear to experience heightened barriers to obtaining cannabis in legalization contexts. CONCLUSIONS: Preliminary indicators on cannabis legalization in Canada show a mixed picture, some similar to US-based developments. While some use increases are observed, these do not necessarily represent indications of increases in cannabis-related harm, also since key (e.g., hospitalization or injury) data are lacking to date. There is a gradual embracing of legal supply sources of cannabis among users, which can be expected to serve public health and safety objectives. At the same time, cannabis use and access among under-age users as a principally vulnerable group do not appear to be hindered or reduced by legalization. BioMed Central 2021-10-07 /pmc/articles/PMC8496143/ /pubmed/34620191 http://dx.doi.org/10.1186/s13011-021-00405-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Short Report
Fischer, Benedikt
Lee, Angelica
Robinson, Tessa
Hall, Wayne
An overview of select cannabis use and supply indicators pre- and post-legalization in Canada
title An overview of select cannabis use and supply indicators pre- and post-legalization in Canada
title_full An overview of select cannabis use and supply indicators pre- and post-legalization in Canada
title_fullStr An overview of select cannabis use and supply indicators pre- and post-legalization in Canada
title_full_unstemmed An overview of select cannabis use and supply indicators pre- and post-legalization in Canada
title_short An overview of select cannabis use and supply indicators pre- and post-legalization in Canada
title_sort overview of select cannabis use and supply indicators pre- and post-legalization in canada
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496143/
https://www.ncbi.nlm.nih.gov/pubmed/34620191
http://dx.doi.org/10.1186/s13011-021-00405-7
work_keys_str_mv AT fischerbenedikt anoverviewofselectcannabisuseandsupplyindicatorspreandpostlegalizationincanada
AT leeangelica anoverviewofselectcannabisuseandsupplyindicatorspreandpostlegalizationincanada
AT robinsontessa anoverviewofselectcannabisuseandsupplyindicatorspreandpostlegalizationincanada
AT hallwayne anoverviewofselectcannabisuseandsupplyindicatorspreandpostlegalizationincanada
AT fischerbenedikt overviewofselectcannabisuseandsupplyindicatorspreandpostlegalizationincanada
AT leeangelica overviewofselectcannabisuseandsupplyindicatorspreandpostlegalizationincanada
AT robinsontessa overviewofselectcannabisuseandsupplyindicatorspreandpostlegalizationincanada
AT hallwayne overviewofselectcannabisuseandsupplyindicatorspreandpostlegalizationincanada